PFB-FDG (solution)
PFB-FDG (solution) is a non-fluorescent galactosidase substrate that can be hydrolyzed into green fluorescent PFB-F (Ex=485 nm, Em=535 nm). PFB-FDG (solution) can be hydrolyzed by β-galactosidases derived from humans, bovine liver, and Aspergillus oryzae, producing a non-leakable green fluorescent product, which enables the detection of enzyme activity in liposomes and via flow cytometry. PFB-FDG (solution) is used for the determination of β-galactosidase activity.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 209540-64-7
- Formule: C39H32F5NO16
- Masse moléculaire:865.66
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Guidelines (The following is our recommended experimental protocol. This protocol serves only as a reference guide, and specific operations should be adjusted according to your actual needs).
β-Galactosidase Activity Assay[6]:
1. Incubate 2 × 105 cells in serum-free DMEM medium containing 25 mM Hepes (pH 7.4) supplemented with 50 μg/mL PFB-FDG at 37°C for 2 h. (Taking monocytes as an example, cell concentration can be adjusted for different cell types)
2. Wash the cells once with pre-chilled PBS.
3. Analyze the cells using a flow cytometer (excitation wavelength Ex=485 nm, emission wavelength Em=535 nm).
PFB-FDG (solution) (20-40 μM; pre-incubated with conduritol B epoxide for 30 min) detects significant lysosomal GBA deficiency (residual activity is 2-4% of normal levels) in fibroblasts from LIMP2-deficient AMRF patients, while significant residual GBA activity is detected in lymphocytes (35% of normal levels), monocytes (47% of normal levels), and monocyte-derived macrophages (32% of normal levels) from AMRF patients[5].
PFB-FDG (solution) (3 h) is a non-leaky fluorescent substrate that can be used to detect functional β-galactosidase synthesized inside POPC/cholesterol/DSPE-PEG5000 liposomes. Enzyme activity is determined by measuring green fluorescence via flow cytometry (FACS) after incubation at 37°C for 3 h[1].
PFB-FDG (solution) enables the detection of senescence-associated β-galactosidase activity via hydrolysis. Results show that senescence-associated β-galactosidase activity is significantly higher in freshly isolated human CD34+ CD133+ hematopoietic progenitor cells from middle-aged donors than in those from young donors[2].
PFB-FDG (solution) (2 h) can be activated by endogenous SA-β-gal in viable human U251.JMJD3wt glioma cells, generating detectable green fluorescence after incubation at a concentration of 3 mg/mL for 2 h[3].
PFB-FDG (solution) (50 μM; overnight) is a viable fluorescent substrate for the β-galactosidase reaction inside microfluidics-derived GUVs. It undergoes efficient hydrolysis during overnight incubation at 37 °C, while the size of GUVs remains stable[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 209540-64-7
-
Masse moléculaire 865.66
-
Formule C39H32F5NO16
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[2]. Navarrete Santos A, et al. Evidences for age-related modulation of human hematopoietic progenitor cell proliferation. Experimental gerontology. 2008 Nov;43(11):1033-8. [Content Brief]
[6]. Navarrete Santos A, et al. Evidences for age-related modulation of human hematopoietic progenitor cell proliferation. Exp Gerontol. 2008 Nov;43(11):1033-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)